- Home
- AMSC vs ALVO Comparison
AMSC vs ALVO Comparison
Compare AMSC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMSC | ALVO |
|---|---|---|
| Founded | 1987 | 2013 |
| Country | United States | Luxembourg |
| Employees | 400 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AMSC | ALVO |
|---|---|---|
| Price | $23.01 | $4.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $61.75 | $7.20 |
| AVG Volume (30 Days) | 743.4K | ★ 810.1K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1806.25 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $900,000.00 | N/A |
| Revenue This Year | $22.95 | $10.83 |
| Revenue Next Year | $15.15 | $20.41 |
| P/E Ratio | $97.26 | ★ $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.08 | $2.94 |
| 52 Week High | $60.18 | $6.53 |
Technical Indicators
Market Signals| Indicator | AMSC | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 34.13 | 47.24 |
| Support Level | N/A | $3.10 |
| Resistance Level | $32.24 | $5.43 |
| Average True Range (ATR) | 1.77 | 0.23 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 13.33 | 39.29 |
Price Performance
Historical ComparisonAbout AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.